John Connolly, Ph.D., interim CEO of 3T Biosciences, will present an overview of the company and 3T-TRACE, a technology that applies a yeast display platform and active machine learning to identify novel targets and T-cell receptors (TCRs), at the Biotech Showcase Digital conference. Hanspeter Gerber, Chief Scientific Officer, will join Dr. Connolly in taking meetings with investors and potential biopharma industry partners throughout the conference. More information is on the Biotech Showcase website including ways to access company presentations and register for the event.

3T At Bts Instagram Graphic